Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
| Autor: | de Bono, Johann Sebastian a, *, Oudard, Stephane c, Ozguroglu, Mustafa d, Hansen, Steinbjørn e, Machiels, Jean-Pascal f, Kocak, Ivo g, Gravis, Gwenaëlle h, Bodrogi, Istvan i, Mackenzie, Mary J j, Shen, Liji k, Roessner, Martin k, Gupta, Sunil k, Sartor, A Oliver b |
|---|---|
| Zdroj: | In The Lancet 2010 376(9747):1147-1154 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|